![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 7/04 | |
A61K 35/76 | |||
C12N 15/863 | |||
A61K 35/74 | |||
C12Q 1/02 |
(11) | Number of the document | 1644492 |
(13) | Kind of document | T |
(96) | European patent application number | 04816752.2 |
Date of filing the European patent application | 2004-06-18 | |
(97) | Date of publication of the European application | 2006-04-12 |
(45) | Date of publication and mention of the grant of the patent | 2009-01-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2004/019866 |
Date | 2004-06-18 |
(87) | Number | WO 2005/047458 |
Date | 2005-05-26 |
(30) | Number | Date | Country code |
03013826 | 2003-06-18 | EP | |
03018478 | 2003-08-14 | EP | |
03024283 | 2003-10-22 | EP |
(72) |
SZALAY, Aladar, A., US
TIMIRYASOVA, Tatyana, US
YU, Yong, A., US
ZHANG, Qian, US
|
(73) |
Genelux Corporation,
3030 Bunker Hill Steet, Suite 310, San Diego, California 92109,
US
|
(54) | MODIFIED RECOMBINANT VACCINIA VIRUSES, USES THEREOF |
MODIFIED RECOMBINANT VACCINIA VIRUSES, USES THEREOF |